Skip to main content
Erschienen in: Familial Cancer 4/2011

01.12.2011

Concerns about inherited risk of breast cancer prior to diagnosis in Japanese patients with breast complaints

verfasst von: Noriko Ando, Yumi Iwamitsu, Masaru Kuranami, Shigemi Okazaki, Kenji Yamamoto, Masahiko Watanabe, Hitoshi Miyaoka

Erschienen in: Familial Cancer | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to reveal characteristics that underlie patients’ expressions of concern about their genetic risk of breast cancer at an initial outpatient clinic visit prior to a definitive diagnosis of cancer. A total of 233 women, at their initial outpatient clinic visits, participated in semi-structured and open-ended interviews that surveyed their anxieties, worries, thoughts, and feelings. Each patient completed a self-administered survey comprising questions about her family history of breast cancer and responded to a questionnaire that assessed psychological distress. Patients were divided into those who expressed concerns about inherited risk of breast cancer during the interview (expression group, n = 39) and those who did not (non-expression group, n = 194). Although patients in the expression group tended to have higher rates of breast cancer in their families, patients without a family history of breast cancer also expressed concerns. We used qualitative content analysis to identify the emotions and thoughts of patients expressing these concerns. Patients with a family history of breast cancer experienced anxiety/worry, risk-reducing behavior, acceptance, objective fact, and denial, whereas patients without a family history of breast cancer experienced anxiety/worry, risk-reducing behavior, surprise/shock, acceptance, objective fact, denial, optimistic thought, regret, and realistic thought. Some patients in the breast clinic had concerns about their inherited risk of cancer, despite lacking a family history of breast cancer. Health care professionals should inquire about family histories and provide appropriate support and counseling to patients as needed, regardless of the patient’s genetic risk for the disease.
Literatur
2.
Zurück zum Zitat Schneider KA (2001) Counseling about cancer: strategies for genetic counselors, 2nd edn. Wiley, New York Schneider KA (2001) Counseling about cancer: strategies for genetic counselors, 2nd edn. Wiley, New York
3.
Zurück zum Zitat Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48(2):232–242PubMed Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48(2):232–242PubMed
4.
Zurück zum Zitat Fackenthal JD, Olopade OI (2007) Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 7(12):937–948PubMedCrossRef Fackenthal JD, Olopade OI (2007) Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 7(12):937–948PubMedCrossRef
5.
Zurück zum Zitat Durfy SJ, Bowen DJ, McTiernan A et al (1999) Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev 8(4 Pt 2):369–375PubMed Durfy SJ, Bowen DJ, McTiernan A et al (1999) Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev 8(4 Pt 2):369–375PubMed
6.
Zurück zum Zitat Shiloh S, Petel Y, Papa M et al (1998) Motivations, perceptions and interpersonal differences associated with interest in genetic testing for breast cancer susceptibility among women at high and average risk. Psychol Health 13(6):1071–1086CrossRef Shiloh S, Petel Y, Papa M et al (1998) Motivations, perceptions and interpersonal differences associated with interest in genetic testing for breast cancer susceptibility among women at high and average risk. Psychol Health 13(6):1071–1086CrossRef
7.
Zurück zum Zitat Jacobsen PB, Valdimarsdottier HB, Brown KL et al (1997) Decision-making about genetic testing among women at familial risk for breast cancer. Psychosom Med 59(5):459–466PubMed Jacobsen PB, Valdimarsdottier HB, Brown KL et al (1997) Decision-making about genetic testing among women at familial risk for breast cancer. Psychosom Med 59(5):459–466PubMed
9.
Zurück zum Zitat Struewing JP, Lerman C, Kase RG et al (1995) Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 4(2):169–173PubMed Struewing JP, Lerman C, Kase RG et al (1995) Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev 4(2):169–173PubMed
10.
Zurück zum Zitat Lerman C, Daly M, Masny A et al (1994) Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12(4):843–850PubMed Lerman C, Daly M, Masny A et al (1994) Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12(4):843–850PubMed
11.
Zurück zum Zitat Sagi M, Kaduri L, Zlotogora J et al (1998) The effect of genetic counseling on knowledge and perceptions regarding risks for breast cancer. J Genet Couns 7(5):417–434CrossRef Sagi M, Kaduri L, Zlotogora J et al (1998) The effect of genetic counseling on knowledge and perceptions regarding risks for breast cancer. J Genet Couns 7(5):417–434CrossRef
12.
Zurück zum Zitat Chaliki H, Loader S, Levenkron JC et al (1995) Women’s receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health 85(8 Pt 1):1133–1135PubMedCrossRef Chaliki H, Loader S, Levenkron JC et al (1995) Women’s receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health 85(8 Pt 1):1133–1135PubMedCrossRef
13.
Zurück zum Zitat Hampel H, Sweet K, Westman JA et al (2004) Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 41(2):81–91PubMedCrossRef Hampel H, Sweet K, Westman JA et al (2004) Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 41(2):81–91PubMedCrossRef
14.
Zurück zum Zitat Foster C, Evans DGR, Eeles R et al (2002) Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort. Br J Cancer 86(8):1209–1216PubMedCrossRef Foster C, Evans DGR, Eeles R et al (2002) Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort. Br J Cancer 86(8):1209–1216PubMedCrossRef
15.
Zurück zum Zitat Brain K, Gray J, Norman P et al (2000) Why do women attend familial breast cancer clinics? J Med Genet 37(3):197–202PubMedCrossRef Brain K, Gray J, Norman P et al (2000) Why do women attend familial breast cancer clinics? J Med Genet 37(3):197–202PubMedCrossRef
16.
Zurück zum Zitat Van Asperen CJ, Van Dijk S, Zoeteweij MW et al (2002) What do women really want to know? Motives for attending familial breast cancer clinics. J Med Genet 39(6):410–414PubMedCrossRef Van Asperen CJ, Van Dijk S, Zoeteweij MW et al (2002) What do women really want to know? Motives for attending familial breast cancer clinics. J Med Genet 39(6):410–414PubMedCrossRef
17.
Zurück zum Zitat Bowen D, McTiernan A, Burke W et al (1999) Participation in breast cancer risk counseling among women with a family history. Cancer Epidemiol Biomarkers Prev 8(7):581–585PubMed Bowen D, McTiernan A, Burke W et al (1999) Participation in breast cancer risk counseling among women with a family history. Cancer Epidemiol Biomarkers Prev 8(7):581–585PubMed
18.
Zurück zum Zitat Rimer BK, Schildkraut JM, Lerman C et al (1996) Participation in a women’s breast cancer risk counseling trial. Who participates? Who declines? High risk breast cancer consortium. Cancer 77(11):2348–2355PubMedCrossRef Rimer BK, Schildkraut JM, Lerman C et al (1996) Participation in a women’s breast cancer risk counseling trial. Who participates? Who declines? High risk breast cancer consortium. Cancer 77(11):2348–2355PubMedCrossRef
19.
21.
Zurück zum Zitat McNair DM, Lorr M, Droppleman LF (1971) Manual for the profile of mood states (POMS). Educational and Industrial Testing Service, San Diego McNair DM, Lorr M, Droppleman LF (1971) Manual for the profile of mood states (POMS). Educational and Industrial Testing Service, San Diego
22.
Zurück zum Zitat Yokoyama K, Araki S, Kawakami N et al (1990) Production of the Japanese edition of profile of mood states (POMS): assessment of reliability and validity. Nippon Koshu Eisei Zasshi—Jpn J Public Health 37(11):913–918 Yokoyama K, Araki S, Kawakami N et al (1990) Production of the Japanese edition of profile of mood states (POMS): assessment of reliability and validity. Nippon Koshu Eisei Zasshi—Jpn J Public Health 37(11):913–918
23.
Zurück zum Zitat Yokoyama K, Araki S (1994) Manual for the Japanese edition of profile of mood states (POMS). Kaneko Shobou, Tokyo Yokoyama K, Araki S (1994) Manual for the Japanese edition of profile of mood states (POMS). Kaneko Shobou, Tokyo
24.
Zurück zum Zitat Ando N, Iwamitsu Y, Kuranami M et al (2009) Psychological characteristics and subjective symptoms as determinants of psychological distress in patients prior to breast cancer diagnosis. Support Care Cancer 17(11):1361–1370. doi:10.1007/s00520-009-0593-7 PubMedCrossRef Ando N, Iwamitsu Y, Kuranami M et al (2009) Psychological characteristics and subjective symptoms as determinants of psychological distress in patients prior to breast cancer diagnosis. Support Care Cancer 17(11):1361–1370. doi:10.​1007/​s00520-009-0593-7 PubMedCrossRef
25.
Zurück zum Zitat Ando N, Iwamitsu Y, Kuranami M et al (2011) Predictors of psychological distress after diagnosis in breast cancer patients and patients with benign breast problems. Psychosomatics 52(1):56–64PubMedCrossRef Ando N, Iwamitsu Y, Kuranami M et al (2011) Predictors of psychological distress after diagnosis in breast cancer patients and patients with benign breast problems. Psychosomatics 52(1):56–64PubMedCrossRef
26.
Zurück zum Zitat Mayring P (2004) Qualitative content analysis. In: Flick U, Kardorff E, Steinke I (eds) A companion to qualitative research. Sage Publications, London Mayring P (2004) Qualitative content analysis. In: Flick U, Kardorff E, Steinke I (eds) A companion to qualitative research. Sage Publications, London
27.
Zurück zum Zitat Taylor EJ (1995) Whys and wherefores: adult patient perspectives of the meaning of cancer. Semin Oncol Nurs 11(1):32–40PubMedCrossRef Taylor EJ (1995) Whys and wherefores: adult patient perspectives of the meaning of cancer. Semin Oncol Nurs 11(1):32–40PubMedCrossRef
28.
Zurück zum Zitat Papadopoulos I, Guo F, Lees S et al (2007) An exploration of the meanings and experiences of cancer of Chinese people living and working in London. Eur J Cancer Care 16(5):424–432CrossRef Papadopoulos I, Guo F, Lees S et al (2007) An exploration of the meanings and experiences of cancer of Chinese people living and working in London. Eur J Cancer Care 16(5):424–432CrossRef
29.
Zurück zum Zitat Elmubarak E, Bromfield E, Bovell-Benjamin AC (2005) Focused interviews with Sudanese Americans: perceptions about diet, nutrition, and cancer. Prev Med 40(5):502–509PubMedCrossRef Elmubarak E, Bromfield E, Bovell-Benjamin AC (2005) Focused interviews with Sudanese Americans: perceptions about diet, nutrition, and cancer. Prev Med 40(5):502–509PubMedCrossRef
30.
Zurück zum Zitat Berckman KL, Austin JK (1993) Causal attribution, perceived control, and adjustment in patients with lung cancer. Oncol Nurs Forum 20(1):23–30PubMed Berckman KL, Austin JK (1993) Causal attribution, perceived control, and adjustment in patients with lung cancer. Oncol Nurs Forum 20(1):23–30PubMed
31.
Zurück zum Zitat Gotay CC (1985) Why me? Attributions and adjustment by cancer patients and their mates at two stages in the disease process. Soc Sci Med 20(8):825–831PubMedCrossRef Gotay CC (1985) Why me? Attributions and adjustment by cancer patients and their mates at two stages in the disease process. Soc Sci Med 20(8):825–831PubMedCrossRef
32.
Zurück zum Zitat Cappelli M, Verma S, Korneluk Y et al (2005) Psychological and genetic counseling implications for adolescent daughters of mothers with breast cancer. Clin Genet 67(6):481–491PubMedCrossRef Cappelli M, Verma S, Korneluk Y et al (2005) Psychological and genetic counseling implications for adolescent daughters of mothers with breast cancer. Clin Genet 67(6):481–491PubMedCrossRef
33.
Zurück zum Zitat Gil F, Mendez I, Sirgo A et al (2003) Perception of breast cancer risk and surveillance behaviours of women with family history of breast cancer: a brief report on a Spanish cohort. Psychooncology 12(8):821–827PubMedCrossRef Gil F, Mendez I, Sirgo A et al (2003) Perception of breast cancer risk and surveillance behaviours of women with family history of breast cancer: a brief report on a Spanish cohort. Psychooncology 12(8):821–827PubMedCrossRef
34.
Zurück zum Zitat Cappelli M, Surh L, Humphreys L et al (1999) Psychological and social determinants of women’s decisions to undergo genetic counseling and testing for breast cancer. Clin Genet 55(6):419–430PubMedCrossRef Cappelli M, Surh L, Humphreys L et al (1999) Psychological and social determinants of women’s decisions to undergo genetic counseling and testing for breast cancer. Clin Genet 55(6):419–430PubMedCrossRef
36.
Zurück zum Zitat Ryan EL, Skinner CS (1999) Risk beliefs and interest in counseling: focus-group interviews among first-degree relatives of breast cancer patients. J Cancer Educ 14(2):99–103PubMed Ryan EL, Skinner CS (1999) Risk beliefs and interest in counseling: focus-group interviews among first-degree relatives of breast cancer patients. J Cancer Educ 14(2):99–103PubMed
37.
Zurück zum Zitat Alper JS, Beckwith J (1993) Genetic fatalism and social policy: the implications of behavior genetics research. Yale J Biol Med 66(6):511–524PubMed Alper JS, Beckwith J (1993) Genetic fatalism and social policy: the implications of behavior genetics research. Yale J Biol Med 66(6):511–524PubMed
38.
Zurück zum Zitat Pijl M, Henneman L, Claassen L et al (2009) Family history of diabetes: exploring perceptions of people at risk in the Netherlands. Prev Chronic Dis 6(2):A54PubMed Pijl M, Henneman L, Claassen L et al (2009) Family history of diabetes: exploring perceptions of people at risk in the Netherlands. Prev Chronic Dis 6(2):A54PubMed
39.
Zurück zum Zitat Pijl M, Timmermans DR, Claassen L et al (2009) Impact of communicating familial risk of diabetes on illness perceptions and self-reported behavioral outcomes: a randomized controlled trial. Diabetes Care 32(4):597–599. doi:10.2337/dc08-1049 PubMedCrossRef Pijl M, Timmermans DR, Claassen L et al (2009) Impact of communicating familial risk of diabetes on illness perceptions and self-reported behavioral outcomes: a randomized controlled trial. Diabetes Care 32(4):597–599. doi:10.​2337/​dc08-1049 PubMedCrossRef
40.
Zurück zum Zitat Lagos VI, Perez MA, Ricker CN et al (2008) Social-cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancer. Psychonosology 17(8):774–782. doi:10.1002/pon.1358 CrossRef Lagos VI, Perez MA, Ricker CN et al (2008) Social-cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancer. Psychonosology 17(8):774–782. doi:10.​1002/​pon.​1358 CrossRef
41.
Zurück zum Zitat Erblich J, Bovbjerg DH, Valdimarsdottir HB (2000) Looking forward and back: distress among women at familial risk for breast cancer. Ann Behav Med 22(1):53–59PubMedCrossRef Erblich J, Bovbjerg DH, Valdimarsdottir HB (2000) Looking forward and back: distress among women at familial risk for breast cancer. Ann Behav Med 22(1):53–59PubMedCrossRef
42.
Zurück zum Zitat Meiser B, Butow P, Schnieden V et al (2000) Psychological adjustment of women at increased risk of developing hereditary breast cancer. Psychol Health Med 5(4):377–388CrossRef Meiser B, Butow P, Schnieden V et al (2000) Psychological adjustment of women at increased risk of developing hereditary breast cancer. Psychol Health Med 5(4):377–388CrossRef
43.
Zurück zum Zitat Yokoyama K, Shimomitsu T, Nomura S (eds) (2009) A collection of case studies on POMS: applying for diagnosis and directions, 6th edn. Kaneko Shobou, Tokyo Yokoyama K, Shimomitsu T, Nomura S (eds) (2009) A collection of case studies on POMS: applying for diagnosis and directions, 6th edn. Kaneko Shobou, Tokyo
44.
Zurück zum Zitat McAllister M, Davies L, Payne K et al (2007) The emotional effects of genetic diseases: implications for clinical genetics. Am J Med Genet Part A 143A(22):2651–2661PubMedCrossRef McAllister M, Davies L, Payne K et al (2007) The emotional effects of genetic diseases: implications for clinical genetics. Am J Med Genet Part A 143A(22):2651–2661PubMedCrossRef
45.
Zurück zum Zitat McAllister M, Payne K, Nicholls S et al (2007) Improving service evaluation in clinical genetics: identifying effects of genetic diseases on individuals and families. J Genet Couns 16(1):71–83PubMedCrossRef McAllister M, Payne K, Nicholls S et al (2007) Improving service evaluation in clinical genetics: identifying effects of genetic diseases on individuals and families. J Genet Couns 16(1):71–83PubMedCrossRef
46.
Zurück zum Zitat Gramling R, Anthony D, Lowery J et al (2005) Association between screening family medical history in general medical care and lower burden of cancer worry among women with a close family history of breast cancer. Genet Med 7(9):640–645PubMedCrossRef Gramling R, Anthony D, Lowery J et al (2005) Association between screening family medical history in general medical care and lower burden of cancer worry among women with a close family history of breast cancer. Genet Med 7(9):640–645PubMedCrossRef
Metadaten
Titel
Concerns about inherited risk of breast cancer prior to diagnosis in Japanese patients with breast complaints
verfasst von
Noriko Ando
Yumi Iwamitsu
Masaru Kuranami
Shigemi Okazaki
Kenji Yamamoto
Masahiko Watanabe
Hitoshi Miyaoka
Publikationsdatum
01.12.2011
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 4/2011
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-011-9464-8

Weitere Artikel der Ausgabe 4/2011

Familial Cancer 4/2011 Zur Ausgabe

Abstract

Abstracts

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.